 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 April 1995 | Volume 122 Issue 7 | Pages 521-529
Objective: To review current knowledge about the hepatopulmonary syndrome, including definition and clinical features, methods for diagnosing it, pathophysiologic mechanisms of the associated vascular dilatations, and considerations in treatment, with emphasis on potential reversibility of the syndrome after liver transplantation.
Data Sources: The MEDLINE database from January 1986 to December 1993 and bibliographies of selected articles.
Study Selection: Case studies and series reporting results from patients with the hepatopulmonary syndrome were reviewed. Clinical reviews and animal studies relevant to the hepatopulmonary syndrome were examined.
Data Extraction: Outcomes, including survival and the frequency of reversibility of the hepatopulmonary syndrome, were extracted from available clinical reports.
Data Synthesis: Mild hypoxemia is multifactorial and occurs in approximately one third of all patients with chronic liver disease. The hepatopulmonary syndrome is one cause of hypoxemia that may also cause dyspnea, platypnea, and orthopnea. Intrapulmonary vascular dilatations and the resulting right-to-left intrapulmonary shunt are characteristic of the syndrome. Pharmacologic treatment with almitrine bismesylate, somatostatin analog, and indomethacin and treatment with plasmapheresis have been disappointing. The underlying cause and the predictors of reversibility of the hepatopulmonary syndrome remain unknown, but it has recently been shown that such reversibility is possible and that contrast-enhanced echocardiography appears to be the most sensitive diagnostic test for detecting intrapulmonary vascular dilatations.
Conclusions: In the context of persisting uncertainty about the cause and treatment of the hepatopulmonary syndrome, future studies must focus on better understanding the pathophysiology of the hepatopulmonary syndrome, predicting reversibility after liver transplantation, and identifying other treatment options.
Author and Article Information
From the Cleveland Clinic Foundation, Cleveland, Ohio.
REVIEW
The Hepatopulmonary Syndrome
Requests for Reprints: James K. Stoller, MD, Section of Respiratory Therapy, Department of Pulmonary and Critical Care Medicine, Cleveland Clinic Foundation, Desk A90, 9500 Euclid Avenue, Cleveland, OH 44106.
Acknowledgments: The authors thank Beth Dobish for her expert assistance in manuscript preparation.
This article has been cited by other articles:
|
|
 |
|
  J.-L. Frossard, E. Schiffer, B. Cikirikcioglu, J. Bourquin, D. R. Morel, and C. M. Pastor Opposite regulation of endothelial NO synthase by HSP90 and caveolin in liver and lungs of rats with hepatopulmonary syndrome Am J Physiol Gastrointest Liver Physiol, October 1, 2007; 293(4): G864 - G870. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Rollan, A. C. Munoz, T. Perez, and J. L. Bratos Value of contrast echocardiography for the diagnosis of hepatopulmonary syndrome Eur J Echocardiogr, October 1, 2007; 8(5): 408 - 410. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. C. Ioachimescu, A. C. Mehta, and J. K. Stoller Hepatopulmonary syndrome following portopulmonary hypertension Eur. Respir. J., June 1, 2007; 29(6): 1277 - 1280. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P W Angus Role of endothelin in systemic and portal resistance in cirrhosis. Gut, September 1, 2006; 55(9): 1230 - 1232. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Thomas, D. J. Christopher, J. Chacko, and J. Ponnaiya Pulmonary arteriovenous malformation in a patient with tuberculosis - an association? Eur. J. Cardiothorac. Surg., August 1, 2006; 30(2): 405 - 407. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. N. Sammour, E. Zuckerman, N. Tov, and R. Gonen Pregnancy Exacerbating Hepatopulmonary Syndrome Obstet. Gynecol., February 1, 2006; 107(2): 455 - 457. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Moorman, M. Saad, S. Kosseifi, and G. Krishnaswamy Hepatitis C Virus and the Lung: Implications for Therapy Chest, October 1, 2005; 128(4): 2882 - 2892. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. P. Georghiou, E. Erez, E. Bruckheimer, O. Dagan, B. A. Vidne, and E. Birk Anomalous Hepatic Venous Drainage Ann. Thorac. Surg., September 1, 2005; 80(3): 1113 - 1115. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. P. Georghiou, E. Birk, and B. A. Vidne Is there a reversal of pulmonary arteriovenous malformation after redirection of anomalous hepatic venous flow to the lungs? Interactive CardioVascular and Thoracic Surgery, June 1, 2005; 4(3): 227 - 231. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. B. Hughes The hepatopulmonary syndrome: NO way out? Eur. Respir. J., January 1, 2005; 25(1): 211 - 212. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ikai, M. Shirai, K. Nishimura, T. Ikeda, T. Kameyama, K. Ueyama, and M. Komeda Maintenance of pulmonary vasculature tone by blood derived from the inferior vena cava in a rabbit model of cavopulmonary shunt J. Thorac. Cardiovasc. Surg., January 1, 2005; 129(1): 199 - 206. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Rodriguez-Roisin, M.J. Krowka, Ph. Herve, M.B. Fallon, and on behalf of the ERS Task Force Pulmonary-Hepatic Pulmonary-Hepatic vascular Disorders (PHD) Eur. Respir. J., November 1, 2004; 24(5): 861 - 880. [Full Text] [PDF]
|
|
|
|
 |
|
 T. B. Kinane and S. J. Westra Case 31-2004 - A Four-Year-Old Boy with Hypoxemia N. Engl. J. Med., October 14, 2004; 351(16): 1667 - 1675. [Full Text] [PDF]
|
|
|
|
|
|
B. Luo, L. Liu, L. Tang, J. Zhang, Y. Ling, and M. B. Fallon ET-1 and TNF-{alpha} in HPS: analysis in prehepatic portal hypertension and biliary and nonbiliary cirrhosis in rats Am J Physiol Gastrointest Liver Physiol, February 1, 2004; 286(2): G294 - G303. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P Schenk, V Fuhrmann, C Madl, G Funk, S Lehr, O Kandel, and C Muller Hepatopulmonary syndrome: prevalence and predictive value of various cut offs for arterial oxygenation and their clinical consequences Gut, December 1, 2002; 51(6): 853 - 859. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Bozkurt, G. Kaya, Y. Yeker, N. Sarimurat, E. Yesildag, G. Tekant, H. Emir, and O. F. Senyuz Arterial Carbon Dioxide Markedly Increases During Diagnostic Laparoscopy in Portal Hypertensive Children Anesth. Analg., November 1, 2002; 95(5): 1236 - 1240. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Stratakos, K. Malagari, E. Broutzos, E. Zakynthinos, C. Roussos, and S. Papiris Dyspnoea and cyanosis in a cirrhotic patient Eur. Respir. J., April 1, 2002; 19(4): 780 - 783. [Full Text] [PDF]
|
|
|
|
|
|
S. L. Starnes, B. W. Duncan, J. M. Kneebone, G. L. Rosenthal, K. Patterson, C. H. Fraga, K. M. Kilian, S. K. Mathur, and F. M. Lupinetti Angiogenic proteins in the lungs of children after cavopulmonary anastomosis J. Thorac. Cardiovasc. Surg., September 1, 2001; 122(3): 518 - 523. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. NUNES, D. LEBREC, M. MAZMANIAN, F. CAPRON, J. HELLER, K. A. TAZI, E. ZERBIB, E. DULMET, R. MOREAU, A. T. DINH-XUAN, et al. Role of Nitric Oxide in Hepatopulmonary Syndrome in Cirrhotic Rats Am. J. Respir. Crit. Care Med., September 1, 2001; 164(5): 879 - 885. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Starnes, B. W. Duncan, J. M. Kneebone, C. H. Fraga, S. States, G. L. Rosenthal, and F. M. Lupinetti Pulmonary microvessel density is a marker of angiogenesis in children after cavopulmonary anastomosis J. Thorac. Cardiovasc. Surg., November 1, 2000; 120(5): 902 - 908. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. P. Carter, K. Sato, Y. Morio, and I. F. McMurtry Inhibition of KCa channels restores blunted hypoxic pulmonary vasoconstriction in rats with cirrhosis Am J Physiol Lung Cell Mol Physiol, November 1, 2000; 279(5): L903 - L910. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Krowka, G. A. Wiseman, O. L. Burnett, J. R. Spivey, T. Therneau, M. K. Porayko, and R. H. Wiesner Hepatopulmonary Syndrome : A Prospective Study of Relationships Between Severity of Liver Disease, PaO2 Response to 100% Oxygen, and Brain Uptake After 99mTc MAA Lung Scanning Chest, September 1, 2000; 118(3): 615 - 624. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Acharya and R. Kartan A Case of Orthodeoxia Caused by an Atrial Septal Aneurysm Chest, September 1, 2000; 118(3): 871 - 874. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Meyer, C. S. White, and K. E. Sherman Diseases of the Hepatopulmonary Axis RadioGraphics, May 1, 2000; 20(3): 687 - 698. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zhang, B. Luo, S.-J. Chen, G. A. Abrams, and M. B. Fallon Endothelin-1 stimulation of endothelial nitric oxide synthase in the pathogenesis of hepatopulmonary syndrome Am J Physiol Gastrointest Liver Physiol, November 1, 1999; 277(5): G944 - G952. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Azzolin, E. Baraldi, S. Carra', G. Guariso, P. Zucchetta, and L. Zancan Exhaled Nitric Oxide and Hepatopulmonary Syndrome in a 6-Year-Old Child Pediatrics, August 1, 1999; 104(2): 299 - 300. [Full Text]
|
|
|
|
 |
|
 K.-N. Lee, H.-J. Lee, W. W. Shin, and W. R. Webb Hypoxemia and Liver Cirrhosis (Hepatopulmonary Syndrome) in Eight Patients: Comparison of the Central and Peripheral Pulmonary Vasculature Radiology, May 1, 1999; 211(2): 549 - 553. [Abstract] [Full Text]
|
|
|
|
|
|
J. R. GOSSAGE and G. KANJ Pulmonary Arteriovenous Malformations . A State of the Art Review Am. J. Respir. Crit. Care Med., August 1, 1998; 158(2): 643 - 661. [Full Text] [PDF]
|
|
|
|
|
|
S Moller, J Hillingso, E Christensen, and J H Henriksen Arterial hypoxaemia in cirrhosis: fact or fiction? Gut, June 1, 1998; 42(6): 868 - 874. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Lee, A. H. Menkis, and H. C. Rosenberg Reversal of Pulmonary Arteriovenous Malformation After Diversion of Anomalous Hepatic Drainage Ann. Thorac. Surg., March 1, 1998; 65(3): 848 - 849. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. A. Couetil, D. P. Houssin, O. Soubrane, P. G. Chevalier, B. E. Dousset, D. Loulmet, A. Achkar, M. J. Tolan, C. I. Amrein, A. Guinvarch, et al. COMBINED LUNG AND LIVER TRANSPLANTATION IN PATIENTS WITH CYSTIC FIBROSIS: A 4 1/2-year experience J. Thorac. Cardiovasc. Surg., November 1, 1995; 110(5): 1415 - 1423. [Abstract] [Full Text]
|
|
Article
